Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Deciding between cash back and rewards credit cards? This guide helps you compare features to find the best option for your financial goals.
26,399 articlesA private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
A little-known bill could change when you claim Social Security. This article breaks down what the proposal might mea...
As major retailers push Beyond Meat into the frozen aisle, investors debate the stock's trajectory. This guide breaks...
Investors react to a key vote in the semiconductor space as IonQ jumps on the SkyWater deal. Here’s what it means for...
Deciding between SOXX and IYW means choosing between a laser focus on chips and a wide tech umbrella. This guide brea...
This article analyzes Summit's Q4 2025 earnings context, what the numbers could imply for the summit (smmt) 2025 earn...
A veteran Wall Street voice argues that safety plus reliable income now drive retiree portfolios, spotlighting five h...
As Sempra wraps up the 2025 fiscal year, investors want clarity on the Q4 2025 earnings trajectory. This article brea...
As AI hype accelerates, Clarivate (CLVT) quietly leans on its defensible data assets to reduce debt and position for ...
As allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
Micron stock surged 700% over the past year, driven by AI memory demand. This guide breaks down what powered the rall...
Pfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...